Cite
APA Citation
Pallett, S. J., Rayment, M., Randell, P., Davies, G. W., & Moore, L. S. (2022). 4 Early identification of high-risk individuals for combination monoclonal antibody therapy is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay. BMJ military health, 168(5), e1. http://access.bl.uk/ark:/81055/vdc_100167559119.0x000004